Practical considerations on the design, execution and analysis of developmental neurotoxicity studies to be published in Neurotoxicology and Teratology

Neurotoxicology and Teratology

Volumn 32, Issue 2, 2010, Pages 121-123

  Maurissen, Jacques ^a  

^a DOW CHEMICAL COMPANY   (United States)

Author keywords

Author; Disclosure; Interpretation; Multiplicity; Recommendation; Reviewer

Indexed keywords

ARTICLE; AUTHOR; DEPENDENT VARIABLE; HYPOTHESIS; MEDICAL RESEARCH; METHODOLOGY; NEUROTOXICITY; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS;

EID: 77649270551     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2009.09.002     Document Type: Note

References (17)

1. Bailar III J.C. Science, statistics, and deception. Ann. Intern. Med. 104 (1986) 259-260
2. Crofton K.M., Foss J.A., Hass U., Jensen K.F., Levin E.D., and Parker S.P. Undertaking positive control studies as part of developmental neurotoxicity testing. A report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol. Teratol. 30 (2008) 266-287
3. Haseman J.K., and Hogan M.D. Selection of the experimental unit in teratology studies. Teratology 12 (1975) 165-172
4. Holson R.R., Freshwater L., Maurissen J.P.J., Moser V.C., and Phang W. Statistical issues and techniques appropriate for developmental neurotoxicity testing: A report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol. Teratol. 30 (2008) 326-348
5. Holson R.R., and Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14 (1992) 221-228
6. Johnson D.H. The insignificance of statistical significance testing. J. Wildl. Manag. 63 3 (1999) 763-772
7. Kerr N.L. HARKing: hypothesizing after the results are known. Pers. Soc. Psychol. Rev. 2 (1998) 196-217
8. Kirk R.E. Experimental design: procedures for the behavioral sciences (1968), Brooks/Cole Publishing Company, Belmont, CA pp. 82-86
9. Ludbrook J. Multiple comparison procedures updated. Clin. Exp. Pharmacol. Physiol. 25 (1998) 1032-1037
10. Muller K.E., Barton C.N., and Benignus V.A. Recommendations for appropriate statistical analysis in toxicologic experiments. NeuroToxicol. 5 2 (1984) 113-126
11. Organisation for Economic Cooperation and Development (OECD. Guideline for the Testing of Chemicals, Test No. 426: Developmental Neurotoxicity Study (2007)
12. Raffaele K.C., Fisher Jr. J.E., Hancock S., Hazelden K., and Sobrian S.K. Determining normal variability in a developmental neurotoxicity test. A report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol. Teratol. 30 (2008) 288-325
13. Shaffer J.P. Multiple hypothesis testing. Annu. Rev. Psychol. 46 (1995) 561-584
14. Tyl R.W., Crofton K., Moretto A., Moser V., Sheets L.P., and Sobotka T.J. A report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol. Teratol. 30 (2008) 349-381
15. USEPA. Health Effects Guidelines OPPTS 870.6300, Developmental Neurotoxicity Study (1998)
16. Ware J.H., Mosteller F., Delgado F., Donnelly C., and Ingelfinger J.A. P values. In: Bailar III J.C., and Mosteller F. (Eds). Medical Uses of Statistics. 2nd Edition (1992), NEJM Books, Boston, Massachusetts 181-200
17. Wilkinson L. Statistical methods in psychology journals. Guidelines and explanations. Am. Psychol. 54 (1999) 594-604